Form 8-K CVS HEALTH Corp For: Feb 12

Go back to Form 8-K CVS HEALTH Corp For: Feb 12

CVS Health (CVS) PT Raised to $76 at Truist Securities

February 13, 2025 6:04 AM EST

Truist Securities analyst David MacDonald raised the price target on CVS Health (NYSE: CVS) to $76.00 (from $60.00) while maintaining a Buy rating.

The analyst comments "We remain bullish on CVS post 4Q marked by top and bottom-line beats while 25 guidance provides an attractive baseline.... More